Prevention and treatment of atherosclerosis with flaxseed-derived compound secoisolariciresinol diglucoside

Current Pharmaceutical Design

Volumn 22, Issue 2, 2015, Pages 214-220

  Prasad, Kailash ^a   Jadhav, Ashok ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Flaxseed; Lipids; Oxidative stress; Regression of atherosclerosis; Secoisolariciresinol diglucoside; Slowing of progression of atherosclerosis; Suppression of atherosclerosis

Indexed keywords

BUTANEDIOL; GLUCOSIDE; SECOISOLARICIRESINOL DIGLUCOSIDE;

ANIMAL; CORONARY ARTERY DISEASE; DISEASE MODEL; FLAX; HUMAN; PHYTOTHERAPY; RABBIT;

ANIMALS; BUTYLENE GLYCOLS; CORONARY ARTERY DISEASE; DISEASE MODELS, ANIMAL; FLAX; GLUCOSIDES; HUMANS; PHYTOTHERAPY; RABBITS;

EID: 84960946116     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612822666151112151130     Document Type: Article

References (88)

1. Prasad K. Pathophysiology of atherosclerosis. In: Chang JB, Olsen ER, Prasad K, Sumpio BE, Eds. Textbook of Angiology. New York, NY: Springer Verlag 2000; pp. 85-105.
2. Prasad K, Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effects of vitamin E. Am Heart J 1993; 125: 958-73.
3. Prasad K, Mantha SV, Kalra J, Lee P. Prevention of hypercholesterolemic atherosclerosis by garlic, an antixoidant. J Cardiovasc Pharmacol Ther 1997; 2: 309-20.
4. Prasad K, Mantha SV, Kalra J, Lee P. Kapoor R, Kamalarajan BRC. Purpurogallin in the prevention of hypercholesterolemic atherosclerosis. Int J of Angiol 1997; 6: 157-66.
5. Prasad K, Mantha SV, Muir AD, Westcott ND. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linoleic acid. Atherosclerosis 1998; 136: 367-75.
6. Prasad K. Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 1997; 132: 69-76.
7. Prasad K. Resveratrol wine and Atherosclerosis. Int J Angiol 2012; 21(1): 7-18.
8. Prasad K, Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J 1993; 125(4): 958-73.
9. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 1999; 99(10): 1355-62.
10. Steinberg D. Antioxidant in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop. September 5-6, 1991, Bethesda, Maryland. Circulation 1992; 85(6): 2337-44.
11. William C, Schindler R, Frei U, Eckardt KV. Increase in oxygen tension stimulate expression of ICAM-1 and VCAM-1 on human endothelial cells. Am J Physiol 1999; 276: H2044-H52.
12. Chiu JJ, Wung BS, Shyy JYJ, Hsieh HJ, Wang DL. Reactive oxygen species are involved in shear stress-induced intercellular adhesion molecule-1 expression in endothelial cells. Artheroscler Thromb Vasc Biol 1997; 17: 3570-7.
13. Martin A, Foxall T, Blumberg JB, Meydani M. Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro. Arterioscler Thromb Vasc Biol 1997; 17: 429-36.
14. Cushing SD, Berliner JA, Valente AJ, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein-1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990; 87: 5134-8.
15. Steinberg D. Oxidant low density lipoprotein: an extreme example of lipoprotein heterogeneity. ISR J Med Sci 1996; 32: 469-72.
16. Wang GP, Deng ZD, Ni J, Qu ZL. Oxidized low density lipoprotein and very low density lipoprotein enhance expression of monocyte chemoattractant protein-1 in rabbit peritoneal exudate macrophage. Atherosclerosis 1997; 133: 31-6.
17. Navab M, Imes SS, Hammo SY, et al. Monocyte transmigration induced by modification of low density lipoprotein in cultures of human aortic wall cells is due to induction of monocyte chemoattractant protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 1991; 88: 2039-46.
18. Hashimoto K, Kataoka N, Nakamura E, Tsujioka K, Kajiya F. Oxidized LDL specifically promotes the initiation of monocyte invasion during transendothelial migration with upregulated PECAM-1 and downregulated VE-cadherin on endothelial junctions. Atherosclerosis 2007; 194: e9-17.
19. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979; 16: 333-7.
20. Naggy L, Tontonoz P, Alvarez GGA, Chen H, Evans RM. Oxidized LDL regulated macrophage gene expression through ligand activity. Cell 1998; 93: 229-40.
21. Rajgopalan S, Meng XP, Ramasamy S, Harrison DG, Gallis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinase in vitro. Implication for atherosclerotic plaque stability. J Clin Invest 1996; 98: 2572-9.
22. Phan SH, McGarry BM, Leoffler KM, Kunkel SL. Regulation of macrophage-derive fibroblast growth factor release by arachidonate metabolites. J Leukocyte Biol 1987; 42: 106-13.
23. Warnholtz A, Wendt M, August M, Munzelt T. Clinical aspects of reactive oxygen species. Biochem Soc Symp 2004; 71: 121-33.
24. White CR, Darley-Usmar V, Berrington WR, et al. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci USA 1996; 93: 8744-9.
25. Zhu X, Lee JY, Timmins JM, et al. Increased cellular cholesterol in macrophage specific Aleca 1 knock-out mice enhances proinflammatory response of macrophage. J Biol Chem 2008; 283: 22930-41.
26. Smalley DM, Lin JH, Curtis ML, Kobari Y, Stemerman MB, Pritchard KA Jr. Native LDL increases endothelial cell adhesiveness by inducing intercellular adhesion molecule-1. Arterioscler Thromb Vasc Biol 1996; 16: 585-90.
27. Allen S, Khan S, Al-Mohanna F, Batten P, Yacoub M. Native low density lipoprotein-induced calcium transients trigger VCAM-1, and E-selectin expression in cultured human vascular endothelial cells. J Clin Invest 1998; 101: 1064-75.
28. Heinloth A, Heeroneir K, Raff U, Wanner C, Galle J. Stimulation of NADPH-oxidase by low-density lipoprotein induces proliferation of human vascular endothelial cells. J Am Soc Neurol 2000; 11: 1819-25.
29. Zhu HL, Xia M, Hou MJ, Tang ZH, Zheng PY, Ling WH. Effects of LOX-1 on expression of adhesion molecules induced by ox-LDL in HUVECs. Zhoung Xin Xueguen Bing Za Zhi 2005; 33: 743-7.
30. Wang L, Gill R, Pederson TL, Higgins LJ, Newman JW, Rutledge JC. Triglyceride-rich lipoprotein lipolysis releases neutral and oxi dized FFAs that induce endothelial cell inflammation. J Lipid Res 2009; 50: 204-13.
31. Eiselein L, Wilson DW, Lame MW, Rutledge JC. Lyposis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonnula occludons-1 and F-actin, and induce apoptosis. Am J Physiol Heart Circ Physiol 2007; 292: H2742-53.
32. Wang YI, Bettaieb A, Sun C, et al. Triglyceride-rich lipoprotein modulates endothelial vascular cell adhesion molecule (VCAM)-1 expression via differential regulation of endoplasmic reticulum stress. PLoS One 2013; 8: e78322.
33. Kitiyakara C, Wilcox CS. Antioxidants for hypertension. Curr Opin Nephrol Hypertens 1998; 7(5): 531-8.
34. Zalba G, Beaumont FJ, San José G, et al. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000; 35(5): 1055-61.
35. Wu R, Millette E, Wu L, de Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and deoxycorticosterone acetate-salt hypertensive rats. J Hypertens 2001; 19: 741-8.
36. Lacy F, Kailasam MT, O’Connor DT, Schmid-Schönbein GW, Parmer RJ. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 2000; 36(5): 878-84.
37. Sagar S, Kallo IJ, Kaul N, Ganguly NK, Sharma BK. Oxygen free radicals in essential hypertension. Mol Cell Biochem 1992; 111(1-2): 103-8.
38. Yasunari K, Maeda K, Nakamura M, Yoshikawa J. Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension 2002; 39(3): 777-80.
39. Chao CU, Lec RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38: 399-403.
40. Dalekos GN, Elisaf M, Bairaktari E, Tsolas O, Simopoulos KC. Increased serum levels of interleukin-1β in systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients. J Lab Clin Med 1997; 129: 300-8.
41. Shalia KK, Mashru MR, Vasvani JB, Mokal RA, Mithbawkar SM, Thakur PK. Circulating levels of cell adhesion molecules in hypertension. Ind J Clin Biochem 2009; 24: 388-97.
42. Malmqrist K, Wallin HN, Held C, Khan T. Soluble cell adhesion molecules in hypertensive concentric left ventricular hypertrophy. J Hypertens 2002; 20: 1563-9.
43. Itoh T, Naqaya N, Ishibashi-Ueda H, et al. Increased plasma monocyte chemoattractant proten-1 level in idiopathic pulmonary arterial hypertension. Respirology 2006; 11: 158-63.
44. Parissis JT, Venetsanou KF, Kalantzi MV, Mentzikof DD, Karas SM. Serum profiles of granulocytes-macrophage coloy-stimulating factor and C-C chemokines in hypertensive patients with or without significant hyperlipidemia. Am J Cardiol 2000; 85: 777-9.
45. Prasad K. Oxidative stress as a mechanism of added sugar-induced cardiovascular disease. Int J Angiol 2014; 23: 217-26.
46. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-21.
47. Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes 1985; 34: 938-41.
48. Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999; 97(7): 889-901.
49. Yan SD, Schmidt AM, Anderson GM, et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994; 269(13): 9889-97.
50. Waultier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001; 280(5): E685-94.
51. Reznikov LL, Walksman J, Azam T, et al. Effect of advanced glycation end products on endotoxin-induced TNF-alpha, IL-1 beta and IL-8 in human peripheral blood mononuclear cells. Clin Nephrol 2004; 61(5): 324-36.
52. Mohamed AM, Syed K, hadden T, Kowluru A. Upregulation of phagocyte-like NADPH oxidase by cytokines in pancreatic beta cells: attenuation of oxidative and nitrosative stress by 2-bromopalmitate. Biochem Pharmacol 2013; 85(1): 109-14.
53. Kalra J, Chaudhary AK, Prasad K. Increased production of oxygen free radicals in cigarette smokers. Int J Exp Pathol 1991; 72(1): 1-7.
54. Prasad K, Dhar I. Role of advanced glycation end products and its receptors in the pathogenesis of cigarette smoke-induced cardiovascular disease. Int J Angiol 2015; 24: (2): 75-80.
55. Pryor WA, Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993; 686 12-27.
56. Kayyali US, Budhiraja R, Pennella CM, et al. Upregulation of xanthine oxidase by tobacco smoke condensate in pulmonary endothelial cells. Toxicol App Pharmacol 2003; 188(1): 59-68.
57. Nicholl ID, Bucala R. Advanced Glycation endproducts and cigarette smoking. Cell Mol Bio (Noisy-le-grand) 1998; 44(7): 1025-33.
58. Radoi V, Lixandru D, Mohora M, Virgolici B. Advanced glycation endproducts in diabetes mellitus: mechanism of action and focused treatment. Proc Rom Acad Ser B 2012; 1: 9-19.
59. Schmidt AM, Yan SD, Yan SF, Stern DM. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 2000; 1498(2-3): 99-111.
60. Schmidt AM, Yan SD, Wautier JL, Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999; 84(5): 489-97.
61. Al-Ghurab BH. Impact of smoking on the IL-β, IL-8, IL-10, IL-17 and TNF-_ production in chronic periodontitis patients. J Asian Sci Res 2013; 3: 462-70.
62. Anil S, Preethanath RS, Alasqah M, Mokeem SA, Anand PS. Increased levels of serum and gingival crevicular fluid monocyte chemoattractant protein-1 in smokers with periodontitis. J. Periodontol 2013; 84(9): e23-8.
63. Kottstorfer J, Kaiser G, Thomas A, et al. The influence of nonosteogenic factors on the expression of M-CSF and VEGF during fracture healing. Injury 2013; 44(7): 930-34.
64. Ooman BD, Mazza G. Flaxseed proteins: A review. Food Chem 1993; 48: 109-14.
65. Westcott ND, Paton D, Acomplex containing lignin, phenolic and aliphatic substances from flax and process for preparing. US Patent 6264853 (July 24, 2001).
66. Smeds AI, Eklund PC, Sjoholm RE, et al. Quantification of a broad spectr4um of lignans in cereals, oilseeds and nuts. J Agric Food Chem 2007; 55: 1337-46.
67. Patel D, Vaghasiya J, Pancholi SS, Paul A. Therapeutic potential of secoisolariciresinol diglucoside. A plant lignin. Int J Pharmaceu Sci Drug Res 2012; 4: 15-8.
68. Paterson J, Dwyer J. Adlercreutz H, Scalbert A, Paul J, McCulough M. Dietary Lignans: Physiology and potential for vardiovascular disease risk reduction. Nutr Rev 2010; 68: 571-603.
69. Prasad K. Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flax-seed. Mol Cell Biochem 1997; 168(1-2): 117-23.
70. Prasad K. Antioxidant activity of secoisolariciresinol diglucosidederived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J 2000; 9(4): 220-5.
71. Prasad K. Hypocholesterolemic and antiatherosclerotic effect of flax lignin complex isolated from flaxseed. Atherosclerosis 2005; 179(2): 269-75.
72. Prasad K. Flax lignin complex slows down the progression of atherosclerosis in hyperlipidemic rabbits. J Cardiovasc Pharmacol Therapeut 2009; 14(1): 38-48.
73. Lee P. and Prasad K. Effects of flaxseed oil on serum lipids and atherosclerosis in hypercholesterolemic rabbits. J Cardiovascular Pharmacol Therapeutic 2003; 8(3): 227-35.
74. Prasad K, Mantha SV, Muir AD and Westcott ND. Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism. Mol Cell Biochem 2000; 206: 141-9.
75. Prasad K. Secoisolariciresinol diglucoside from flaxseed delays the devdelopemnet of type 2 diabetes in Zucker rat. J Lab Clin Med 2000; 138: 32-9.
76. Prasad K. Suppression of phosphoenolpyruvate carboxykinase gene expression by secoisolariciresinol diglucoside (SDG), a new antidiabetic agent. Int J Angiol 2002; 11: 1-2.
77. Prasad K. Antihypertensive activity of secoisolariciresinol diglucoside (SDG) islated from flaxseed: Role of guanylate cyclase. Int J Angiol 2004; 13: 7-14.
78. Prasad K. Secoisolariciresinol diglucoside (SDG) isolated from flaxseed, an alternative to ACE inhibitors in the treatment of hypertension. Int J Angiol 2013; 22: 235-8.
79. Cornish SM, Chilibeck PD, Paus-Jennsen L, et al. A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults. Appl Physiol Nutr Metabol 2009; 34(2): 89-98.
80. Hallund J, Tetens I, Bugel S, Tholstrup T and Bruun JM. The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women. Nutr Metabol Cardiovasc Dis 2008; 18(7): 497-502.
81. Dupasquier CM, Dibrov E, Kneesh AL, et al. Dietary flaxseed inhibits atherosclerosis in the LDL-receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. American Journal of Physiology. Heart Circ Physiol 2007; 293(4): H2394-402.
82. Lee P and Prasad K. Effect of flaxseed oil on serum lipids and therosclerosis on hypercholesterolemia on rabbits. J Cardiovasc Pharmacol Therapeutics 2003; 8: 227-35.
83. Prasad K. Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis 2005; 179: 269-74.
84. Penumathsa SV, Koneru S, Zhan L, et al. Secoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hypercholesterolemic myocardium. J Mol Cell Cardiol 2008; 44: 170-9.
85. Fukumitsu S, Aida K, Ueno N, Ozawa S, Takahashi Y, Kobori M. Flaxseed lignin attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice. Brit J Nutr 2008; 100(3): 669-76.
86. Fukumitsu S, Aida K, Shimizu H, Toyoda K. Flaxseed lignan lowers blood cholesterol and decreases liver disease risk factors in moderately hypercholesterolemic men. Nut Res 2010; 30(7): 441-6.
87. Hallund J, Ravn-Haren, Bugel S, Tholstrup T, Tetens I. A lignan complex isolated from flaxseed does not affect plasma lipid concentrations or antioxidant capacity in healthy postmenopausal women. J Nutr 2006; 136: 112-6
88. Prasad K. Regression of hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Atherosclerosis 2008; 197(1): 34-42.